Program: main session

ISAD > Georg RAJKA International Symposium on Atopic Dermatitis (ISAD) > Welcome to Australia > Program: main session

Rajka 2025 Melbourne motto:
History, Memory, and Retelling

Keynote and Invited speakers

  • Sébastien BARBAROT, France
  • Thomas BIEBER, Switzerland
  • Eung Ho CHOI, South Korea
  • Sandipan DHAR, India
  • Carsten FLOHR, UK
  • Cindy MA, Australia
  • Marlys FASSET, USA
  • Amir LATIFF, Malaysia
  • Ji Hyun LEE, South Korea
  • Adrian LOWE, Australia
  • Wei LI, China
  • Laura MacKAY, Australia
  • Laurent MISERY, France
  • Erere OTROFANOWEI, Nigeria
  • Amy S. PALLER, USA
  • Murlidhar RAJAGOPALAN, India
  • Johannes RING, Germany
  • Robert SIDBURY, USA
  • Alain TAÏEB, France
  • Kim THOMAS, UK
  • Fang WANG, China
  • Andreas WOLLENBERG, Germany
  • Xu YAO, China

Preliminary-Program

Please note all timings are based on Melbourne time zone.
➜ Australian Eastern Standard Time (AEDT) – UTC+11

Friday, October 24th, 2025 — PaCeCAD
PATIENT-CENTERED CARE IN ATOPIC DERMATITIS SESSIONS
08:30 P1. Misinformation in Atopic Dermatitis and Digital Tools to address it
Chair: Jean-François STALDER, France / Fanny SENTENAC, France
08:30
The concept of Patient Centred Approach in chronic skin disease (PCA)

Jean-François STALDER, France
08:35
Tackling misinformation in social media: the example of Topical Corticosteroid Withdrawal (TSW)

Mikael ALSTERHOLM, Sweden
08:45
Title to be confirmed

Alpana MOHTA, India
08:55
Title to be confirmed

Hanof AHMED, Qatar
09:05
What should we expect from Large Language Model Chat bots in therapeutic education: uses, expected benefits, risks?

Pranvera SULEJMANI, USA
09:15 RT
Round Table: New communication tools in therapeutic education
Challenges, contributions, and limitations (Results of a survey on the role of AI in the management of AD)

All speakers
+ Kelly BARTA (ITSAN), USA
+ Kristin BELLENSON (NEA), USA
 
10:00 Refreshment Break 30 min.
 
10:30 P2. Atopic Dermatitis, Global Health Perspectives Worldwide
Chair: Fahafahantsoa RABENJA RAPELANORO, Madagascar / Tina MESARIČ, Slovenia
10:30
Australia compared to the Rest of the World

John SU, Australia
10:50
Eczema Support Australia: role and place of a patient advocacy group in the Australian patient journey

Melanie FUNK, Australia
11:00 RT
Round Table: Participants from other regions of the world
Given the particularities of each country, what is the common ground that would allow us to joint our efforts towards the same goal? Perhaps better acces to the right medicines? What are the 3 main stakes in terms of needs, tools and care?

All speakers
+ Masaki FUTAMURA, Japan
+ Ellis HON, Hong-Kong
+ Kin Fon LEONG, Malaysia
+ Rachel OGOLA, Kenya
+ Raquel ORFALI, Brazil
+ Yong Kwang TAY, Singapore

11:45
Closure

Jean-François STALDER, including closing remarks by ISAD President Alain TAÏEB
 
11:50 Lunch break (not included) 1h00
 

Friday, October 24th, 2025 — Symposium
#day1
13:00 Welcome addresses
13:00
Welcome to Melbourne

John SU, Australia
13:05
ISAD President address

Alain TAÏEB, France
13:10
Welcome address from ACD President

Adrienne LEE, Australia (Melbourne)
13:15 IL1
Introduction into History of ISAD and Rajka meetings

Johannes RING, Germany
13:25
Centenial of the Birth of Georg RAJKA

Suzanne RAJKA, Norway
13:30
Reporting from the Organization of Care pre meeting

Roberto TAKAOKA, Brazil
13:35
Reporting from the WHO meeting
 
13:40 S1. Innate and adaptive Immunity*
Chairs: Magdalena TRZECIAK, Poland / Anne HALBERT, Australia (Perth)
13:40 KL1
Keynote lecture: T-helper-2 cells in AD- learning from Inborn Errors of Immunity

Cindy MA, Australia (Sydney)
14:10 IL2
AD presentations in Inborn Errors of Immunity

Amir LATIFF , Malaysia
14:25 OL1
15 min. short communication, selected in the call for abstract submissions
14:40 OL2
15 min. short communication, selected in the call for abstract submissions
 
14:55 S2. Regulation of T cell immunity & Systemic immunity and immune crosstalk
Chairs: Dirk Jan HIJNEN, The Netherlands / Jason FOK, Australia
14:55 KL2
Keynote lecture: Skin-Resident Lymphocyte diversity and function - implications for AD

Laura MacKAY, Australia (Melbourne)
15:25 IL3
Basophils and Neuroimmune crosstalk - therapeutic implications

Fang WANG, China
15:40 OL3
15 min. short communication, selected in the call for abstract submissions
15:55 OL4
15 min. short communication, selected in the call for abstract submissions
 
16:10 PS1 Poster presentations session 130 min. Refreshment Break & Visit Exhibits
 
16:40 S3. Skin barrier
Chairs: Kyu-Han KIM, South Korea / Linda MARTIN, Australia
16:40 KL3
Keynote lecture: Skin barrier research in atopic dermattis in the era of biologics

Eung Ho CHOI, South Korea
17:10 OL5
15 min. short communication, selected in the call for abstract submissions
17:25 OL6
15 min. short communication, selected in the call for abstract submissions
17:40 OL7
15 min. short communication, selected in the call for abstract submissions
 
17:55 Refreshment Break & Visit Exhibits & Posters
19:30 WELCOME RECEPTION & GEORG RAJKA CENTENNIAL JUBILEE Carlton Gardens, Melbourne Gallery in the Melbourne Museum (20 minutes walk from the hotel, 1.4km) 3h00
 

Saturday, October 25th, 2025 — Symposium
#day2
08:30 S4. Historical and new perspectives on atopic dermatitis*
Chairs: Lin MA, China / Dedee MURREL, Australia (Sydney)
08:30 KL4
Keynote lecture: 100 years from the birth of Georg RAJKA

Johannes RING, Germany
08:55 IL4
The evolving landscape of Atopic Dermatitis - definitions and consensus

Robert SIDBURY, USA
09:20 IL5
Towards personalised therapy and potential disease modification

Thomas BIEBER, Switzerland
09:45 IL6
New systemic therapies for AD

Amy S. PALLER, USA
 
10:10 PS2 Poster presentations session 230 min. Refreshment Break & Visit Exhibits
 
10:40 S5. Epidemiology and outcome research
Chairs: Peter SCHMID-GRENDELMEIER, Switzerland / Shyamali DHARMAGE, Australia
10:40 KL5
Keynote lecture: Primary prevention of atopic dermatitis

Carsten FLOHR, UK
11:05 IL7
Protein bound skin ceramides in the development of AD & food allergy

Adrian LOWE, Australia
11:30 IL8
Running remote eczema trials - opportunities and risks

Kim THOMAS, UK
11:55 OL8
15 min. short communication, selected in the call for abstract submissions
12:10 OL9
15 min. short communication, selected in the call for abstract submissions
 
12:25 Lunch break 1h35
 
14:00 S6. Itch*
Chairs: Martin STEINHOFF, Qatar / Diana PURVIS, New-Zealand
14:00 KL6
Keynote lecture: Itch and pain in atopic dermatitis and prurigo nodularis

Laurent MISERY, France
14:30 IL9
IL-31-dependent neuroinflammation

Marlys FASSET, USA
15:00 IL10
History and contribution of Georg RAJKA

Laurent MISERY, France
15:15 OL10
15 min. short communication, selected in the call for abstract submissions
15:30 OL11
15 min. short communication, selected in the call for abstract submissions
 
15:45 PS3 Poster presentations session 330 min. Refreshment Break & Visit Exhibits
 
16:15 S7. What’s new from the industry
Chairs: Chia Yu CHU, Taiwan, China / George A. VARIGOS, Australia
16:15 SL1
Title to be confirmed

Presentation from Pfizer Inc. (Corporate Member & Platinum sponsor)
16:35 SL2
Title to be confirmed

Presentation from Corporate Member Diamond sponsor
 
16:50 Refreshment Break & Visit Exhibits & Posters 2h40
19:30 Local Organizing Committee Cultural invitation President’s dinner at Arts Centre Melbourne 3h00
 

Sunday, October 26th, 2025 — Symposium
#day3
08:30 S8. Microbiome and atopic dermatitis
Chairs: Ousmane FAYE, Mali / Pablo FERNANDEZ-PENÃS, Australia (Perth)
08:30 KL7
Keynote lecture: Title to be confirmed

John COMMON, UK
09:00 IL11
Skin environmental and microbial crosstalk in AD pathogenesis

Xu YAO, China
09:30 OL12
15 min. short communication, selected in the call for abstract submissions
09:45 OL13
15 min. short communication, selected in the call for abstract submissions
 
10:00 PS4 Poster presentations session 430 min. Refreshment Break & Visit Exhibits
 
10:30 S9. Systemic and new therapies for atopic dermatitis
Chairs: Yong Kwang TAY, Singapore / Li-Chuen WONG, Australia (Sydney)
10:30 KL8
Keynote lecture: Clinical and molecular heterogeneities of atopic dermatitis

Wei LI, China
11:00 IL12
Cannabinoids in atopic dermatitis - exploring new treatment horizons

Ji-Hyun LEE, South Korea
11:15 OL14
15 min. short communication, selected in the call for abstract submissions
11:30 OL15
15 min. short communication, selected in the call for abstract submissions
11:45 OL16
15 min. short communication, selected in the call for abstract submissions
 
12:00 Lunch break 1h00
 
13:00 S10. Complications and comorbidities of atopic dermatitis
Chairs: Roberto TAKAOKA, Brazil / Dedee MURREL, Australia (Sydney)
13:00 KL9
Keynote lecture: Infectious complications and comorbidities of AD

Andreas WOLLENBERG, Germany
13:30 IL13
Title to be confirmed

Murlidhar RAJAGOPALAN, India
13:45 OL17
15 min. short communication, selected in the call for abstract submissions
14:00 OL18
15 min. short communication, selected in the call for abstract submissions
14:15 OL19
15 min. short communication, selected in the call for abstract submissions
 
14:30 S11. Extremes of age
Chairs: Ellis HON, Hong Kong / Anousha YAZDABADI, Australia (Melbourne)
14:30 KL10
Keynote lecture: Managing children with moderate-to-severe AD & complications of therapy

Sébastien BARBAROT, France
15:00 IL14
Paediatric AD - syndromes and mimickers

Sandipan DHAR, India
15:15 OL20
15 min. short communication, selected in the call for abstract submissions
15:30 OL21
15 min. short communication, selected in the call for abstract submissions
 
15:45 PS5 Poster presentations session 530 min. Refreshment Break & Visit Exhibits
 
16:15 S12. Atopic dermatitis in diverse skin types
Chairs: Kin Fon LEONG, Malaysia / Lena LY, Australia
16:15 KL11
Keynote lecture: Title to be confirmed

Erere OTROFANOWEI, Nigeria
16:35 IL15
16:55 OL22
15 min. short communication, selected in the call for abstract submissions
17:10 OL23
15 min. short communication, selected in the call for abstract submissions
 
17:25 Closing ceremony 20 min.
Best poster/presentation awards, local best posters

John SU, Australia
Next Rajka Symposium: Beijing, China

Lin MA, China
Closing remarks

Alain TAÏEB, France

 
20250531180651
➜ Download the program [PDF]